Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity

European Urology

Volumn 64, Issue 3, 2013, Pages 372-378

  Nepple, Kenneth G ^a,b   Stephenson, Andrew J ^c   Kallogjeri, Dorina ^a   Michalski, Jeff ^a   Grubb III, Robert L ^a   Strope, Seth A ^a   Haslag Minoff, Jennifer ^a   Piccirillo, Jay F ^a   Ciezki, Jay P ^c   Klein, Eric A ^c   Reddy, Chandana A ^c   Yu, Changhong ^c   Kattan, Michael W ^c   Kibel, Adam S ^a,d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Comorbidity; Comparative effectiveness research; Prostatectomy; Prostatic neoplasms; Radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER SURGERY; COHORT ANALYSIS; COMORBIDITY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT;

COMORBIDITY; COMPARATIVE EFFECTIVENESS RESEARCH; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION THERAPY;

ACADEMIC MEDICAL CENTERS; AGED; BRACHYTHERAPY; CHI-SQUARE DISTRIBUTION; COMORBIDITY; COMPARATIVE EFFECTIVENESS RESEARCH; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84881139818     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.03.005     Document Type: Article

References (34)

1. B.R. Konety, J.E. Cowan, and P.R. Carroll Patterns of primary and secondary therapy for prostate cancer in elderly men: Analysis of data from CaPSURE J Urol 179 2008 1797 1803
2. S. Houterman, M.L. Janssen-Heijnen, A.J. Hendrikx, H.A. van den Berg, and J.W. Coebergh Impact of comorbidity on treatment and prognosis of prostate cancer patients: A population-based study Crit Rev Oncol Hematol 58 2006 60 67
3. T.J. Guzzo, P. Dluzniewski, R. Orosco, E.A. Platz, A.W. Partin, and M. Han Prediction of mortality after radical prostatectomy by Charlson comorbidity index Urology 76 2010 553 557
4. P.C. Albertsen, D.F. Moore, W. Shih, Y. Lin, H. Li, and G.L. Lu-Yao Impact of comorbidity on survival among men with localized prostate cancer J Clin Oncol 29 2011 1335 1341
5. A. Nanda, M.H. Chen, M.H. Braccioforte, B.J. Moran, and A.V. D'Amico Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction JAMA 302 2009 866 873
6. P.A. Groome, S.L. Rohland, D.R. Siemens, M.D. Brundage, J. Heaton, and W.J. Mackillop Assessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidates Cancer 117 2011 3943 3952
7. M. Froehner, R. Koch, R.J. Litz, O.W. Hakenberg, and M.P. Wirth Which patients are at the highest risk of dying from competing causes ≤10 years after radical prostatectomy? BJU Int 110 2012 206 210
8. T.J. Daskivich, K. Chamie, and L. Kwan Overtreatment of men with low-risk prostate cancer and significant comorbidity Cancer 117 2011 2058 2066
9. A. Berglund, H. Garmo, C. Tishelman, L. Holmberg, P. Stattin, and M. Lambe Comorbidity, treatment and mortality: A population based cohort study of prostate cancer in PCBaSe Sweden J Urol 185 2011 833 839
10. F. Abdollah, M. Sun, and R. Thuret A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006 Eur Urol 59 2011 88 95
11. J. Hadley, K.R. Yabroff, M.J. Barrett, D.F. Penson, C.S. Saigal, and A.L. Potosky Comparative effectiveness of prostate cancer treatments: Evaluating statistical adjustments for confounding in observational data J Natl Cancer Inst 102 2010 1780 1793
12. A.S. Kibel, J.P. Ciezki, and E.A. Klein Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era J Urol 187 2012 1259 1265
13. S.A. Boorjian, R.J. Karnes, and R. Viterbo Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer Cancer 117 2011 2883 2891
14. F. Abdollah, J. Schmitges, and M. Sun Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: A population-based analysis Int J Urol 19 2012 836 844
15. M.R. Cooperberg, A.J. Vickers, J.M. Broering, and P.R. Carroll Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer Cancer 116 2010 5226 5234
16. B.M. Psaty, and D.S. Siscovick Minimizing bias due to confounding by indication in comparative effectiveness research: The importance of restriction JAMA 305 2010 897 898
17. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation J Chronic Dis 40 1987 373 383
18. J.F. Piccirillo, R.M. Tierney, I. Costas, L. Grove, and E.L. Spitznagel Jr. Prognostic importance of comorbidity in a hospital-based cancer registry JAMA 291 2004 2441 2447
19. R.B. Hines, C. Chatla, and H.L. Bumpers Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer J Clin Oncol 27 2009 4339 4345
20. D.T. Mangano, I.C. Tudor, and C. Dietzel The risk associated with aprotinin in cardiac surgery N Engl J Med 354 2006 353 365
21. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
22. N. Bhojani, U. Capitanio, and N. Suardi The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: A population-based study on 17,845 patients Int J Radiat Oncol Biol Phys 76 2010 342 348
23. C. Hyde Rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer Int J Radiat Oncol Biol Phys 77 2010 1607
24. S. Punnen, M.R. Cooperberg, N. Sadetsky, and P.R. Carroll Androgen deprivation therapy and cardiovascular risk J Clin Oncol 29 2011 3510 3516
25. P.L. Nguyen, Y. Je, and F.A. Schutz Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: A meta-analysis of randomized trials JAMA 306 2011 2359 2366
26. R.M. Hoffman, S.N. Stone, W.C. Hunt, C.R. Key, and F.D. Gilliland Effects of misattribution in assigning cause of death on prostate cancer mortality rates Ann Epidemiol 13 2003 450 454
27. L. Liu, A.L. Coker, X.L. Du, J.N. Cormier, C.E. Ford, and S. Fang Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer J Surg Oncol 97 2008 583 591
28. C. Jeldres, N. Suardi, and P. Perrotte Survival after radical prostatectomy and radiotherapy for prostate cancer: A population-based study Can Urol Assoc J 3 2009 13 21
29. A. Kutikov, M.R. Cooperberg, A.T. Paciorek, R.G. Uzzo, P.R. Carroll, and S.A. Boorjian Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram Prostate Cancer Prostatic Dis 15 2012 374 379
30. A.V. D'Amico, M.H. Chen, A.A. Renshaw, M. Loffredo, and P.W. Kantoff Androgen suppression and radiation vs radiation alone for prostate cancer: A randomized trial JAMA 299 2008 289 295
31. M. Bolla, T.M. de Reijke, and G. Van Tienhoven Duration of androgen suppression in the treatment of prostate cancer N Engl J Med 360 2009 2516 2527
32. J.L. Gore, L. Kwan, S.P. Lee, R.E. Reiter, and M.S. Litwin Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer J Natl Cancer Inst 101 2009 888 892
33. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
34. P. Stattin, E. Holmberg, J.E. Johansson, L. Holmberg, J. Adolfsson, and J. Hugosson Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study J Natl Cancer Inst 102 2010 950 958